Tumor Cell Lines

KY821

  • BSL

    1

  • 219
Leukemia cells. Dt=27-37 hr.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

KY-821

Species

Human

Cat.No

ABC-TC0553

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphocyte-like

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Myeloid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Leukemia Cell Lines

Description

KY821 is a human acute myelomonocytic leukemia cell line derived from peripheral blood of a 28-year old male. The cells exhibit lymphocyte-like morphology and suspension culture properties, the cell may grow slowly at first after thawing. KY821 cells are characterized by its granulocytic maturation numerous double minute chromosomes (dmin) derived from chromosome 8, and the 8q22–24 containing MYC is amplified in dmin. KY821 cells also carry concurrent oncogenic NRAS and TP53R175H/- mutations, and these AML cells are matained by sustained expression of mutant p53. The fore-mentioned properties make KY821 and its clone cell line suitable for studying drug resistance mechanism and its relation with dmin. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast and Bacteria.

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • The KY821 cell line is used in AML pathogenisis research, drug screening and resistance studies. These studies are closely associatedwith its molecular mechanisms underlying hematopoietic neoplasms. In the durg preclinical screening, the KY821 show different responses and effects to each drug due to its multiple hematopoietic growth factors. Thus KY821 would be an ideal model for drug comparative studies, enable the identification of more precise resistant clone.

  • Test Item
  • Flow Cytometry
  • Result
  • KY821 (no staining)

    KY821 (lgG ctrl)

    KY821 (full staining)

    Flow cytometry plot of KY821 (no staining), showing HMB-45 expression to be 0%.Flow cytometry plot of KY821 (lgG ctrl), showing HMB-45 expression to be 8.03×10^-3%.Flow cytometry plot of KY821, showing HMB-45 expression to be 71.9%.

    The percentage of HMB-45 expression in KY821 Cell Line was detected by flow cytometry to be approximately 71.9%.

Inquiring KY821

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button